Page 232 - Read Online

Page 8 of 9 Van der Merwe et al. Vessel Plus 2019;3:24 I http://dx.doi.org/10.20517/2574-1209.2019.17

coronary intervention. N Engl J Med 2009;360:213-24.
8. Pijls NH, Fearon WF, Tonino PAO, Siebert U, Ikeno F, et al. Fractional flow reserve vs. angiography for guiding percutaneous
coronary intervention in patients with multivessel coronary artery disease. J Am Coll Cardiol 2010;56:177-184.
9. De Bruyne B, Pijls NH, Kalesan B, Barbato E, Tonino PA, et al. FAME 2 Trial Investigators. Fractional flow reserve-guided PCI
versus medical therapy in stable coronary disease. N Engl J Med 2012;367:991-1001.
10. De Bruyne B, Fearon WF, Pijls NH, Barbato E, Tonino P, et al. FAME 2 Trial Investigators. Fractional flow reserve-guided PCI for
stable coronary artery disease. N Engl J Med 2014;371:1208-17.
11. Johnson NP, Tóth GG, Lai D, Zhu H, Açar G, et al. Prognostic value of fractional flow reserve: linking physiologic severity to clinical
outcomes. J Am Coll Cardiol 2014;64:1641-54.
12. Mangiacapra F, Barbato E. From SYNTAX to FAME, a paradigm shift in revascularization strategies: the key role of fractional flow
reserve in guiding myocardial revascularization. J Cardiovasc Med 2011;12:538-542.
13. Nam CW, Mangiacapra F, Entjes R, Chung IS, Sels JW, et al. FAME Study Investigators. Functional SYNTAX score for risk
assessment in multivessel coronary artery disease. J Am Coll Cardiol 2011;58:1211-8.
14. Harskamp RE, Alexander JH, Ferguson TB, Hager R, Mack MJ, et al. Frequency and predictors of internal mammary artery graft
failure and subsequent clinical outcomes: insights from the Project of Ex-vivo Vein Graft Engineering via Transfection (PREVENT)
IV trial. Circulation 2016;133:131-8.
15. Toth GG, Johnson NP, Jeremias A, Pellicano M, Vranckx P, et al. Standardization of Fractional Flow Reserve Measurements. J Am
Coll Cardiol 2016;68:742-53.
16. Kern MJ. My approach to the patient diagnosed with significant left main disease: Use of FFR, IVUS, and OCT. Trends Cardiovasc
Med 2016;26:660-1.
17. Johnson NP, Gould KL, Di Carli MF, Taqueti VR. Invasive FFR and Noninvasive CFR in the Evaluation of Ischemia: What Is the
Future? J Am Coll Cardiol 2016;67:2772-88.
18. Engstrom T, Kelbaek H, Helqvist S, Høfsten DE, Kløvgaard L, et al. Complete revascularisation versus treatment of the culprit lesion
only in patients with ST-segment elevation myocardial infarction and multivessel disease (DANAMI-3- PRIMULTI): an open-label,
randomised controlled trial. Lancet 2015;386:665-71.
19. Toth GG, De Bruyne B, Rusinaru D, Di Gioia G, Bartunek J, et al. Impact of Right Atrial Pressure on Fractional Flow Reserve
Measurements: Comparison of Fractional Flow Reserve and Myocardial Fractional Flow Reserve in 1,600 Coronary Stenoses. JACC
Cardiovasc Interv 2016;9:453-9.
20. van de Hoef TP, Nolte F, EchavarrIa-Pinto M, van Lavieren MA, Damman P, et al. Impact of hyperaemic microvascular resistance
on fractional flow reserve measurements in patients with stable coronary artery disease: insights from combined stenosis and
microvascular resistance assessment. Heart 2014;100:951-9.
21. Meuwissen M, Chamuleau SA, Siebes M, Schotborgh CE, Koch KT, et al. Role of variability in microvascular resistance on fractional
flow reserve and coronary blood flow velocity reserve in intermediate coronary lesions. Circulation 2001;103:184-7.
22. Di Gioia G, Pellicano M, Toth GG, Casselman F, Adjedj J, et al. Fractional Flow Reserve-Guided Revascularization in Patients With
Aortic Stenosis. Am J Cardiol 2016;117:1511-5.
23. Pellicano M, De Bruyne B, Toth GG, Casselman F, Wijns W, et al. Fractional flow reserve to guide and to assess coronary artery
bypass grafting. Eur Heart J 2016;38:1959-68.
24. Aggarwal V, Stanislawski MA, Maddox TM, Nallamothu BK, Grunwald G, et al. Safety and effectiveness of drug-eluting versus bare-
metal stents in saphenous vein bypass graft percutaneous coronary interventions: insights from the Veterans Affairs CART program. J
Am Coll Cardiol 2014;64:1825-36.
25. Neumann FJ, Sousa-Uva M, Ahlsson A, Alfonso F, Banning AP, et al. ESC Scientific Document Group. 2018 ESC/EACTS Guidelines
on myocardial revascularization. Eur Heart J 2019;40:87-165.
26. Dimitrova KR, Hoffman DM, Geller CM, Dincheva G, Ko W, et al. Arterial grafts protect the native coronary vessels from
atherosclerotic disease progression. Ann Thorac Surg 2012;94:475-81.
27. Weintraub WS, Grau-Sepulveda MV, Weiss JM, O’Brien SM, Peterson ED, et al. Comparative effectiveness of revascularization
strategies. N Engl J Med 2012;366:1467-76.
28. Serruys PW, Morice MC, Kappetein AP, Colombo A, Holmes DR, et al. Percutaneous coronary intervention versus coronary-artery
bypass grafting for severe coronary artery disease. N Engl J Med 2009;360:961-72.
29. Mohr FW, Morice MC, Kappetein AP, Feldman TE, Ståhle E, et al. Coronary artery bypass graft surgery versus percutaneous
coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical
SYNTAX trial. Lancet 2013;381:629-38.
30. Farkouh ME, Domanski M, Sleeper LA, Siami FS, Dangas G, et al. FREEDOM Trial Investigators. Strategies for multivessel
revascularization in patients with diabetes. N Engl J Med 2012;367:2375-84.
31. Park SJ, Ahn JM, Kim YH, Park DW, Yun SC, et al. Trial of everolimus-eluting stents or bypass surgery for coronary disease. N Engl
J Med 2015;372:1204-12.
32. Botman CJ, Schonberger J, Koolen S, Penn O, Botman H, et al. Does stenosis severity of native vessels influence bypass graft
patency? A prospective fractional flow reserve-guided study. Ann Thorac Surg 2007;83:2093-97.
33. Toth G, De Bruyne B, Casselman F, De Vroey F, Pyxaras S, et al. Fractional flow reserve-guided versus angiography-guided coronary
artery bypass graft surgery. Circulation 2013;128:1405-11.
34. Fournier S, Toth GG, De Bruyne B, Johnson NP, Ciccarelli G,et al. Six-Year Follow-Up of Fractional Flow Reserve-Guided Versus